DP
Moleculin Biotech Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Annamycin (AnnAraC) | Relapsed or Refractory Acute Myeloid Leukemia (AML) | Phase 3 |
| Annamycin | Soft Tissue Sarcoma (STS) Lung Metastases | Clinical |
| WP1066 | Brain Tumors, Pancreatic & Other Cancers | Preclinical/Phase 1 |
| WP1122 | Viral Infections & Cancer | Preclinical |
Leadership Team at Moleculin Biotech
WV
Walter V. Klemp
Founder, President, CEO, Chairman
JP
Jonathan P. Foster
Executive VP & Chief Financial Officer